Ko Sugibayashi
2PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Nov 07, 2022
Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study.Shunsuke Kondo, Satoru Iwasa, Takafumi Koyama
|Oct 21, 2022
Safety, tolerability, pharmacokinetics and preliminary antitumour activity of an antisense oligonucleotide targeting STAT3 (danvatirsen) as monotherapy and in combination with durvalumab in Japanese patients with advanced solid malignancies: a phase 1 study.Tomohiro Nishina, Tomoko Fujita, Naoto Yoshizuka
Pageof 1
